comparison of glp-1 agonists Treatment with Receptor View of GLP-1 receptor agonists
Description
& Mullenbach, G
Blood 125 , 284295 (2015)

(Lausanne) 12 , 721198 (2021)

Preclinical studies in diet-induced obesity rodent models are ongoing to evaluate its efficacy, safety, and tolerability as a potential therapy for type 2 diabetes and obesity

Cinelli, M

Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism
